AstraZeneca says Klygefa recommended for EU approval in generalized myasthenia gravis
AstraZeneca said its Klygefa therapy was recommended for EU approval to treat adults with generalized myasthenia gravis.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.